- TheStreet.com•3 hours ago
CEO Soriot says the company's pipeline is progressing well, and predicts a boost to full-year earnings from a decline in the pound.
- The Wall Street Journal•8 hours ago
While Brexit provided an expected boost to core earnings for GlaxoSmithKline, it also led to a big write-down—the latest in a series of surprises stemming from Britain’s vote to leave the EU.
Pre-Market: 45.450.33 (0.73%) as of 7:42 AM EDT
|Bid||45.44 x 600|
|Ask||45.47 x 5100|
|52wk Range||37.24 - 45.49|
|Day's Range||44.75 - 45.24|
|Avg Vol (3m)||3,510,038|
As of 4:02 PM EDT. Market closed.